Omron invests in South Korean healthcare startup Sky Labs

South Korea-based healthcare startup Sky Labs has attracted investments with OMRON Ventures, Omron Group's ent...

November 6, 2025 | Thursday | News
Korea's Samsung Bioepis gains full rights to BYOOVIZ biosimilar from Biogen in Europe

South Korea-based Samsung Bioepis has entered into an Asset Purchase Agreement (APA) with Biogen regarding Samsung Bioep...

November 3, 2025 | Monday | News
Korea's SK pharmteco and LOTTE BIOLOGICS partner to strengthen global ADC CDMO capabilities

South Korea-based SK pharmteco and LOTTE BIOLOGICS have signed a Letter of Intent (LOI) for a strategic collaboration to...

October 30, 2025 | Thursday | News
IASO Bio partners with GC Cell to bring CAR-T therapy to Korea

Nanjing IASO Biotechnology has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy "Fucaso" (Equecab...

October 31, 2025 | Friday | News
Korea announces 5th Comprehensive Plan for high-tech medical complexes

The Ministry of Health and Welfare, South Korea government, has announced the the launch of the 5th Comprehensive Plan f...

October 27, 2025 | Monday | News
SK Biopharma launches JV with Eurofarma for AI-based epilepsy management platform

South Korea-based SK Biopharmaceuticals has announced the establishment of Mentis Care, Inc., a joint venture (JV) with ...

October 23, 2025 | Thursday | News
Chinese startup Phrontline Biopharma joins hands with Samsung Bioepis to co-develop ADC assets

South Korea-based Samsung Bioepis Co., Ltd. and Chinese startup Phrontline Biopharma, a clinical-stage biotechnology com...

October 21, 2025 | Tuesday | News
Samsung partners with Grail in $110 M deal to expand early cancer testing across Asia

South Korea's Samsung C&T (SCT), Samsung Electronics (SEC), and US-based GRAIL, Inc. have signed a binding Letter of...

October 21, 2025 | Tuesday | News
Boehringer Ingelheim inks $991 M deal with Korea's AimedBio for cancer antibody-drug conjugate portfolio

Germany's Boehringer Ingelheim and Korean biotech startup AimedBio have announced a global collaboration and licensing a...

October 17, 2025 | Friday | News
Texas Medical Center unveils BioBridge with Republic of Korea

A new collaboration between Texas Medical Center, the world’s largest innovation hub, and the Osong Medical Innova...

October 16, 2025 | Thursday | News
South Korea selects PacBio HiFi Technology for National Pangenome Project

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced that its HiFi sequencin...

October 14, 2025 | Tuesday | News
Korea's GC Biopharma secures contract manufacturing rights for Shingles vaccine from Curevo

GC Biopharma, a South Korean biopharmaceutical company, has signed an agreement with Curevo Vaccine to secure contract m...

October 13, 2025 | Monday | News
Korea's Samsung Biologics introduces optimised manufacturing framework ExellenS™

South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has unveiled ...

October 10, 2025 | Friday | News
Rentschler Biopharma further expands services in Japan and South Korea

Germany-based Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) ...

October 8, 2025 | Wednesday | News
Agilent and Chungnam National University to build Open Biopharma Research Hub in South Korea

Agilent Technologies Inc. has recently announced a strategic partnership with Chungnam National University&nbs...

October 3, 2025 | Friday | News
South Korea's Boryung to acquire global rights to Taxotere from Sanofi for €175 M

South Korea's Boryung Corporation has signed an asset purchase agreement with the global biopharma company Sanofi to acq...

October 6, 2025 | Monday | News
Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub

The PPD™ clinical research business of Thermo Fisher Scientific, has announced a new research and development (R&a...

October 6, 2025 | Monday | News
Korea's Celltrion buys Eli Lilly plant in US for KRW 460 B

South Korea-based Celltrion has signed an agreement with Eli Lilly to acquire a biopharmaceutical drug substance (DS) ma...

September 30, 2025 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls